Atlas Venture Associates Opportunity I, L.P. insider trades: Kymera Therapeutics (KYMR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Atlas Venture Associates Opportunity I, L.P. reports to the SEC
and 4 more companies
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | KYMR | ↓ Sell | 292,039 | $42.20 | $12.3M | Direct | Mar 13, 2024 (0d) |
| Mar 13, 2024 | KYMR | ↓ Sell | 61,318 | $42.20 | $2.6M | Indirect | Mar 13, 2024 (0d) |
| Mar 1, 2024 | DYN | ↓ Sell | 29,435 | $30.05 | $885K | Direct | Mar 5, 2024 (4d) |
| Mar 1, 2024 | DYN | ↓ Sell | 17,099 | $30.05 | $514K | Indirect | Mar 5, 2024 (4d) |
| Feb 28, 2024 | DYN | ↓ Sell | 654,471 | $24.30 | $15.9M | Direct | Feb 28, 2024 (0d) |
| Feb 28, 2024 | DYN | ↓ Sell | 153,367 | $24.30 | $3.7M | Indirect | Feb 28, 2024 (0d) |
| Feb 23, 2024 | DYN | ↓ Sell | 463,403 | $22.64 | $10.5M | Direct | Feb 23, 2024 (0d) |
| Feb 23, 2024 | DYN | ↓ Sell | 37,386 | $22.70 | $849K | Indirect | Feb 23, 2024 (0d) |
| Feb 8, 2024 | XLO | ↓ Sell | 733 | $0.64 | $469 | Direct | Feb 9, 2024 (1d) |
| Feb 8, 2024 | XLO | ↓ Sell | 267 | $0.64 | $171 | Indirect | Feb 9, 2024 (1d) |
| Jan 23, 2024 | IRON | ↓ Sell | 102,500 | $67.65 | $6.9M | Indirect | Jan 25, 2024 (2d) |
| Jan 23, 2024 | IRON | ↓ Sell | 47,500 | $67.65 | $3.2M | Direct | Jan 25, 2024 (2d) |
| Jan 12, 2024 | XLO | ↓ Sell | 3,106 | $0.85 | $3K | Direct | Jan 16, 2024 (4d) |
| Jan 12, 2024 | XLO | ↓ Sell | 1,129 | $0.85 | $960 | Indirect | Jan 16, 2024 (4d) |
| Jan 10, 2024 | IRON | ↓ Sell | 30,000 | $64.00 | $1.9M | Direct | Jan 12, 2024 (2d) |
| Jan 10, 2024 | IRON | ↓ Sell | 20,000 | $64.00 | $1.3M | Indirect | Jan 12, 2024 (2d) |
| Dec 14, 2023 | IRON | ↓ Sell | 114,099 | $61.45 | $7.0M | Direct | Dec 14, 2023 (0d) |
| Dec 14, 2023 | IRON | ↓ Sell | 76,064 | $61.45 | $4.7M | Indirect | Dec 14, 2023 (0d) |
| Aug 15, 2023 | IRON | ↓ Sell | 286,069 | $52.52 | $15.0M | Direct | Aug 16, 2023 (1d) |
| Aug 15, 2023 | IRON | ↓ Sell | 72,931 | $52.40 | $3.8M | Indirect | Aug 16, 2023 (1d) |
| Jan 12, 2023 | KYMR | ↓ Sell | 98,811 | $30.22 | $3.0M | Direct | Jan 13, 2023 (1d) |
| Jan 12, 2023 | KYMR | ↓ Sell | 27,663 | $30.22 | $836K | Indirect | Jan 13, 2023 (1d) |
| Dec 15, 2022 | KYMR | ↓ Sell | 298,638 | $31.36 | $9.4M | Direct | Dec 16, 2022 (1d) |
| Dec 15, 2022 | KYMR | ↓ Sell | 83,606 | $31.36 | $2.6M | Indirect | Dec 16, 2022 (1d) |
| Dec 12, 2022 | DYN | ↑ Buy | 934,581 | $10.70 | $10.0M | Direct | Dec 14, 2022 (2d) |
| Nov 3, 2022 | KYMR | ↓ Sell | 171,893 | $30.01 | $5.2M | Direct | Nov 4, 2022 (1d) |
| Nov 3, 2022 | KYMR | ↓ Sell | 48,123 | $30.01 | $1.4M | Indirect | Nov 4, 2022 (1d) |
| Nov 1, 2022 | KYMR | ↓ Sell | 225,556 | $30.26 | $6.8M | Direct | Nov 1, 2022 (0d) |
| Nov 1, 2022 | KYMR | ↓ Sell | 63,146 | $30.26 | $1.9M | Indirect | Nov 1, 2022 (0d) |
| Sep 19, 2022 | THRD | ↑ Buy | 300,000 | $17.00 | $5.1M | Direct | Sep 19, 2022 (0d) |
| Jun 17, 2022 | DAWN | ↑ Buy | 766,667 | $15.00 | $11.5M | Direct | Jun 22, 2022 (5d) |
| Jan 11, 2022 | VIGL | ↑ Buy | 535,000 | $14.00 | $7.5M | By Atlas Venture Fund XII, L.P. | Jan 11, 2022 (0d) |
| Dec 14, 2021 | IKNA | ↓ Sell | 26,278 | $14.67 | $386K | Direct | Dec 14, 2021 (0d) |
| Jun 23, 2021 | GBIO | ↓ Sell | 184,736 | $25.05 | $4.6M | Direct | Jun 23, 2021 (0d) |
| Jun 23, 2021 | GBIO | ↓ Sell | 342 | $25.05 | $9K | Indirect | Jun 23, 2021 (0d) |
| Jun 1, 2021 | DAWN | ↑ Buy | 500,000 | $16.00 | $8.0M | Indirect | Jun 2, 2021 (1d) |
| Mar 30, 2021 | IKNA | ↑ Buy | 125,000 | $16.00 | $2.0M | Indirect | Dec 14, 2021 (259d) |
| Jun 24, 2019 | AKRO | ↑ Buy | 270,000 | $16.00 | $4.3M | Indirect | Jun 25, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYMR insiders
Open-market trades in the last 12 months
About Atlas Venture Associates Opportunity I, L.P.'s insider trades
Atlas Venture Associates Opportunity I, L.P. is a 10% owner of Kymera Therapeutics (KYMR). Since Jun 24, 2019, it has reported 7 open-market purchases worth $48.4M and 31 sales worth $127.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (8 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.